Global Hematology Oncology Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Report ID: ARS12545 | Category: Healthcare | Pages: 120 | Format: PDF | Published Date: December 18,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3350.00 Multi User-$5700.00

Report Description
View Table of Contents

Report Summary

This report aims to provide a comprehensive presentation of the global market for Hematology Oncology, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematology Oncology.

The Hematology Oncology market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Hematology Oncology market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hematology Oncology manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

The global Hematology Oncology market size in 2022 is 8766.2 million US dollars, and it is expected to be 14830.0 million US dollars by 2029, with a compound annual growth rate of 7.80% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Hematology Oncology market include Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies Inc. (U.S.), and Myriad Genetics Inc. (U.S.). The share of the top 3 players in the Hematology Oncology market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Hematology Oncology market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Chemotherapy accounted for XX% of Hematology Oncology market in 2022. Targeted Therapy share of XX%.
Hospitals accounted for XX% of the Hematology Oncology market in 2022. Clinical Testing Institutes accounts for XX%.

Chapter Outline
Chapter 1: Introduces the product overview, and global Hematology Oncology market status and forecast by region.
Chapters 2-3: Segmented the global Hematology Oncology market by type, and application. Analyze the revenue of market segments from different perspectives.
Chapter 4: Analysis of the competitive environment of Hematology Oncology market participants. This mainly includes the revenue and market share of the top players, along with the players' M&A and expansion in recent years.
Chapters 5-9: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Hematology Oncology market country segmentation data.
Chapter 10: Analyzes the main companies in the Hematology Oncology industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
Chapter 11: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
Chapter 12: The main points and conclusions of the report.
Chapter 13: Concludes with an explanation of the data sources and research methods.

Highlights-Regions

North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
South America
Brazil
Argentina
Colombia
MEA
Saudi Arabia
Egypt
Nigeria

Player list
Illumina, Inc. (U.S.)
Thermo Fisher Scientific Inc. (U.S.)
F. Hoffmann-La Roche Ltd. (Switzerland)
Agilent Technologies Inc. (U.S.)
Myriad Genetics Inc. (U.S.)
Beijing Genomics Institute (BGI)
Perkin Elmer Inc. (U.S.)
Foundation Medicine Inc. (U.S.)
PacBio (U.S.)
Oxford Nanopore Technologies plc. (U.K.)
Paradigm Diagnostics Inc. (U.S.)
Caris Life Sciences (Japan)
Partek, Incorporated (U.S.)
Eurofins Scientific (Luxembourg)
Qiagen (Germany)

Types list
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy

Application list
Hospitals
Clinical Testing Institutes
Patient Self-Testing
Other End-Users

Table of Content

1 Hematology Oncology Market Overview
1.1 Hematology Oncology Product Overview
1.1.1 Hematology Oncology Product Scope
1.1.2 Hematology Oncology Market Status and Outlook
1.2 Global Hematology Oncology Market Size Overview by Region 2018 VS 2022VS 2029
1.3 Global Hematology Oncology Market Size by Region (2018-2029)
1.4 Global Hematology Oncology Historic Market Size by Region (2018-2023)
1.5 Global Hematology Oncology Market Size Forecast by Region (2023-2029)
1.6 Key Regions, Hematology Oncology Market Size (2018-2029)
1.6.1 North America Hematology Oncology Market Size (2018-2029)
1.6.2 Europe Hematology Oncology Market Size (2018-2029)
1.6.3 Asia-Pacific Hematology Oncology Market Size (2018-2029)
1.6.4 Latin America Hematology Oncology Market Size (2018-2029)
1.6.5 Middle East & Africa Hematology Oncology Market Size (2018-2029)
2 Hematology Oncology Market Overview by Type
2.3 Global Hematology Oncology Market Size by Type: 2018 VS 2022 VS 2029
2.4 Global Hematology Oncology Historic Market Size by Type (2018-2023)
2.5 Global Hematology Oncology Forecasted Market Size by Type (2023-2029)
2.6 Key Regions Market Size Segment by Type (2018-2029)
2.6.1 North America Hematology Oncology Market Size Breakdown by Type (2018-2029)
2.6.2 Europe Hematology Oncology Market Size Breakdown by Type
2.6.3 Asia-Pacific Hematology Oncology Market Size Breakdown by Type
2.6.4 Latin America Hematology Oncology Market Size Breakdown by Type
2.6.5 Middle East and Africa Hematology Oncology Market Size Breakdown by Type
3 Hematology Oncology Market Overview by Application
3.3 Global Hematology Oncology Market Size by Application: 2018 VS 2022 VS 2029
3.4 Global Hematology Oncology Historic Market Size by Application (2018-2023)
3.5 Global Hematology Oncology Forecasted Market Size by Application (2023-2029)
3.6 Key Regions Market Size Segment by Application (2018-2029)
3.6.1 North America Hematology Oncology Market Size Breakdown by Application (2018-2029)
3.6.2 Europe Hematology Oncology Market Size Breakdown by Application
3.6.3 Asia-Pacific Hematology Oncology Market Size Breakdown by Application
3.6.4 Latin America Hematology Oncology Market Size Breakdown by Application
3.6.5 Middle East and Africa Hematology Oncology Market Size Breakdown by Application
4 Hematology Oncology Competition Analysis by Players
4.1 Global Hematology Oncology Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hematology Oncology as of 2022)
4.3 Date of Key Players Enter into Hematology Oncology Market
4.4 Global Top Players Hematology Oncology Headquarters and Area Served
4.5 Key Players Hematology Oncology Product Solution and Service
4.6 Competitive Status
4.6.1 Hematology Oncology Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 North America Hematology Oncology Market Segment by Country
5.1 North America Hematology Oncology Market Size by Country (2018-2029)
5.2 United States
5.3 Canada
6 Europe Hematology Oncology Market Segment by Country
6.1 Europe Hematology Oncology Market Size by Country (2018-2029)
6.2 Germany
6.3 France
6.4 U.K.
6.5 Italy
6.6 Russia
6.7 Nordic
6.8 Rest of Europe
7 Asia-Pacific Hematology Oncology Market Segment by Country
7.1 Asia-Pacific Hematology Oncology Market Size by Region (2018-2029)
7.2 China
7.3 Japan
7.4 South Korea
7.5 Southeast Asia
7.6 India
7.7 Australia
7.8 Rest of Asia-Pacific
8 Latin America Hematology Oncology Market Segment by Country
8.1 Latin America Hematology Oncology Market Size by Country (2018-2029)
8.2 Mexico
8.3 Brazil
8.4 Rest of Latin America
9 Middle East and Africa Hematology Oncology Market Segment by Country
9.1 Middle East & Africa Hematology Oncology Market Size by Country (2018-2029)
9.2 Turkey
9.3 Saudi Arabia
9.4 UAE
9.5 Rest of Middle East & Africa
10 Manufacturers Profiles
10.1  Illumina, Inc. (U.S.)
10.1.1 Illumina, Inc. (U.S.) Information
10.1.2 Business Overview
10.1.3 Illumina, Inc. (U.S.) Hematology Oncology Revenue, Gross Margin
10.1.4 Hematology Oncology Products Offered
10.1.5 Illumina, Inc. (U.S.) Recent Development
10.2  Thermo Fisher Scientific Inc. (U.S.)
10.2.1 Thermo Fisher Scientific Inc. (U.S.) Information
10.2.2 Business Overview
10.2.3 Thermo Fisher Scientific Inc. (U.S.) Hematology Oncology Revenue, Gross Margin
10.2.4 Hematology Oncology Products Offered
10.2.5 Thermo Fisher Scientific Inc. (U.S.) Recent Development
10.3  F. Hoffmann-La Roche Ltd. (Switzerland)
10.3.1 F. Hoffmann-La Roche Ltd. (Switzerland) Information
10.3.2 Business Overview
10.3.3 F. Hoffmann-La Roche Ltd. (Switzerland) Hematology Oncology Revenue, Gross Margin
10.3.4 Hematology Oncology Products Offered
10.3.5 F. Hoffmann-La Roche Ltd. (Switzerland) Recent Development
10.4  Agilent Technologies Inc. (U.S.)
10.4.1 Agilent Technologies Inc. (U.S.) Information
10.4.2 Business Overview
10.4.3 Agilent Technologies Inc. (U.S.) Hematology Oncology Revenue, Gross Margin
10.4.4 Hematology Oncology Products Offered
10.4.5 Agilent Technologies Inc. (U.S.) Recent Development
10.5  Myriad Genetics Inc. (U.S.)
10.5.1 Myriad Genetics Inc. (U.S.) Information
10.5.2 Business Overview
10.5.3 Myriad Genetics Inc. (U.S.) Hematology Oncology Revenue, Gross Margin
10.5.4 Hematology Oncology Products Offered
10.5.5 Myriad Genetics Inc. (U.S.) Recent Development
10.6  Beijing Genomics Institute (BGI)
10.6.1 Beijing Genomics Institute (BGI) Information
10.6.2 Business Overview
10.6.3 Beijing Genomics Institute (BGI) Hematology Oncology Revenue, Gross Margin
10.6.4 Hematology Oncology Products Offered
10.6.5 Beijing Genomics Institute (BGI) Recent Development
10.7  Perkin Elmer Inc. (U.S.)
10.7.1 Perkin Elmer Inc. (U.S.) Information
10.7.2 Business Overview
10.7.3 Perkin Elmer Inc. (U.S.) Hematology Oncology Revenue, Gross Margin
10.7.4 Hematology Oncology Products Offered
10.7.5 Perkin Elmer Inc. (U.S.) Recent Development
10.8  Foundation Medicine Inc. (U.S.)
10.8.1 Foundation Medicine Inc. (U.S.) Information
10.8.2 Business Overview
10.8.3 Foundation Medicine Inc. (U.S.) Hematology Oncology Revenue, Gross Margin
10.8.4 Hematology Oncology Products Offered
10.8.5 Foundation Medicine Inc. (U.S.) Recent Development
10.9  PacBio (U.S.)
10.9.1 PacBio (U.S.) Information
10.9.2 Business Overview
10.9.3 PacBio (U.S.) Hematology Oncology Revenue, Gross Margin
10.9.4 Hematology Oncology Products Offered
10.9.5 PacBio (U.S.) Recent Development
10.10  Oxford Nanopore Technologies plc. (U.K.)
10.10.1 Oxford Nanopore Technologies plc. (U.K.) Information
10.10.2 Business Overview
10.10.3 Oxford Nanopore Technologies plc. (U.K.) Hematology Oncology Revenue, Gross Margin
10.10.4 Hematology Oncology Products Offered
10.10.5 Oxford Nanopore Technologies plc. (U.K.) Recent Development
10.11  Paradigm Diagnostics Inc. (U.S.)
10.11.1 Paradigm Diagnostics Inc. (U.S.) Information
10.11.2 Business Overview
10.11.3 Paradigm Diagnostics Inc. (U.S.) Hematology Oncology Revenue, Gross Margin
10.11.4 Hematology Oncology Products Offered
10.11.5 Paradigm Diagnostics Inc. (U.S.) Recent Development
10.12  Caris Life Sciences (Japan)
10.12.1 Caris Life Sciences (Japan) Information
10.12.2 Business Overview
10.12.3 Caris Life Sciences (Japan) Hematology Oncology Revenue, Gross Margin
10.12.4 Hematology Oncology Products Offered
10.12.5 Caris Life Sciences (Japan) Recent Development
10.13  Partek, Incorporated (U.S.)
10.13.1 Partek, Incorporated (U.S.) Information
10.13.2 Business Overview
10.13.3 Partek, Incorporated (U.S.) Hematology Oncology Revenue, Gross Margin
10.13.4 Hematology Oncology Products Offered
10.13.5 Partek, Incorporated (U.S.) Recent Development
10.14  Eurofins Scientific (Luxembourg)
10.14.1 Eurofins Scientific (Luxembourg) Information
10.14.2 Business Overview
10.14.3 Eurofins Scientific (Luxembourg) Hematology Oncology Revenue, Gross Margin
10.14.4 Hematology Oncology Products Offered
10.14.5 Eurofins Scientific (Luxembourg) Recent Development
10.15  Qiagen (Germany)
10.15.1 Qiagen (Germany) Information
10.15.2 Business Overview
10.15.3 Qiagen (Germany) Hematology Oncology Revenue, Gross Margin
10.15.4 Hematology Oncology Products Offered
10.15.5 Qiagen (Germany) Recent Development
11 Hematology Oncology Market Dynamics
11.1 Hematology Oncology Industry Trends
11.2 Hematology Oncology Growth Drivers
11.3 Hematology Oncology Market Challenges
11.4 Hematology Oncology Market Restraints
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 A Methodology
13.1.1 Research Process
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 B Data Source
13.2.1 Legal Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Hematology Oncology Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?